AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+7.03%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.77B
AUM Growth
+$3.77B
(+12%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
28.51%
Holding
375
New
122
Increased
57
Reduced
81
Closed
81
Top Buys
| 1 |
GSK
GSK
|
$70.8M |
| 2 |
Sanofi
SNY
|
$51.5M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$50.9M |
| 4 |
argenx
ARGX
|
$44.9M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$41.7M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$50.8M |
| 2 |
Incyte
INCY
|
$50.2M |
| 3 |
Keurig Dr Pepper
KDP
|
$45.5M |
| 4 |
UnitedHealth
UNH
|
$36.9M |
| 5 |
SentinelOne
S
|
$36.2M |
Sector Composition
| 1 | Healthcare | 68.31% |
| 2 | Consumer Staples | 10.4% |
| 3 | Consumer Discretionary | 9.57% |
| 4 | Technology | 7.34% |
| 5 | Communication Services | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intuitive Surgical
ISRG
$170B
| $10.8M | 0.15% | 32,000 -65,212 | -67% | -$22M |
|
77
Workday
WDAY
$61.6B
| $10.5M | 0.14% | 38,118 -33,835 | -47% | -$9.34M |
|
78
CRISPR Therapeutics
CRSP
$4.71B
| $10.5M | 0.14% | 168,000 -432,012 | -72% | -$27M |
|
79
Academy Sports + Outdoors
ASO
$3.56B
| $10.5M | 0.14% | +158,668 | New | +$10.5M |
|
|
80
SentinelOne
S
$6.29B
| $10.2M | 0.14% | 372,000 -1,320,497 | -78% | -$36.2M |
|
81
Kenvue
KVUE
$39.7B
| $10.1M | 0.14% | +470,000 | New | +$10.1M |
|
82
Prothena Corp
PRTA
$441M
| $10.1M | 0.14% | +278,000 | New | +$10.1M |
|
83
Uber
UBER
$196B
| $10.1M | 0.14% | 164,000 -270,130 | -62% | -$16.6M |
|
84
NVIDIA
NVDA
$4.24T
| $9.89M | 0.14% | 19,977 +2,098 | +12% | +$1.04M |
|
85
Foot Locker
FL
$2.36B
| $9.89M | 0.14% | 317,574 -347,083 | -52% | -$10.8M |
|
86
Mural Oncology
MURA
$35.7M
| $9.82M | 0.13% | +1,658,000 | New | +$9.82M |
|
87
Wyndham Hotels & Resorts
WH
$6.61B
| $9.65M | 0.13% | +120,000 | New | +$9.65M |
|
88
Wynn Resorts
WYNN
$13.2B
| $9.58M | 0.13% | 105,155 +49,155 | +88% | +$4.48M |
|
89
Esperion Therapeutics
ESPR
$448M
| $9.57M | 0.13% | +3,200,000 | New | +$9.57M |
|
90
BILL Holdings
BILL
$4.72B
| $9.31M | 0.13% | +114,114 | New | +$9.31M |
|
|
HYPD
91
Hyperion DeFi, Inc. Common Stock
HYPD
$34.7M
| $9.11M | 0.12% | 4,378,000 +1,290,979 | +42% | +$2.69M |
|
92
Reviva Pharmaceuticals
RVPH
$30.6M
| $9.08M | 0.12% | 1,764,000 +1,164,000 | +194% | +$5.99M |
|
93
FibroGen
FGEN
$47.8M
| $8.65M | 0.12% | 9,764,000 +1,872,000 | +24% | +$1.66M |
|
94
Adobe
ADBE
$151B
| $8.6M | 0.12% | 14,408 -3,396 | -19% | -$2.03M |
|
95
Zura Bio
ZURA
$133M
| $8.52M | 0.12% | 1,824,000 +244,000 | +15% | +$1.14M |
|
96
Charles River Laboratories
CRL
$8.04B
| $8.51M | 0.12% | 36,000 -120,000 | -77% | -$28.4M |
|
97
Live Nation Entertainment
LYV
$38.6B
| $8.28M | 0.11% | 88,440 -59,648 | -40% | -$5.58M |
|
98
Coupang
CPNG
$52.1B
| $8.1M | 0.11% | +500,000 | New | +$8.1M |
|
99
Performance Food Group
PFGC
$15.9B
| $8.06M | 0.11% | +116,616 | New | +$8.06M |
|
100
Aquestive Therapeutics
AQST
$456M
| $7.93M | 0.11% | 3,924,000 -876,000 | -18% | -$1.77M |
|